Top Markets
Coin of the day
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Clasificación en acciones #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Precio por acción
$1.84
Última sincronización: 2026-08-11
Capitalización bursátil
$3.51M
Cambio (1 día)
0.46%
Cambio (1 año)
-62.71%
País
US
Comercio Dogwood Therapeutics, Inc. (DWTX)

Categoría

Historial de desdoblamientos de acciones de Dogwood Therapeutics, Inc. (DWTX)
La acción Dogwood Therapeutics, Inc. (símbolo: DWTX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 16, 2026.
Una acción DWTX comprada antes de Aug 16, 2026 equivaldría hoy a 0 acciones DWTX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE